Details for 2020729204
Up to date per 01.04.2026
Actions
Details for 2020729204
Granted/Registered
European Patent
30.03.2022 A
04.06.2025 B1
23.05.2019
US
201962851996 P
A61K 31/505 20060101AFI20201127BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
No representatives present
Inventor
BHATTACHARYA, SouvikNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US
BIETH, BrunoNovartis Pharma AG Postfach 4002 BaselCH
CABANSKI, MaciejNovartis Pharma AG Postfach 4002 BaselCH
CENNI, BrunoNovartis Pharma AG Postfach Novartis Institutes for Biomed. Research 4002 BaselCH
DE BUCK, StefanNovartis Pharma AG Postfach 4002 BaselCH
KAUL, MartinNovartis Pharma AG Postfach Novartis Institutes for Biomed. Research 4002 BaselCH
KINHIKAR, ArvindNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US
RADIVOJEVIC, AndrijanaNovartis Pharmaceuticals Corporation 1 Health Plaza East Hanover, New Jersey 07936US
SEVERIN, ThomasNovartis Pharma AG Postfach 4002 BaselCH
STORIM, JulianNovartis Pharma AG Postfach 4002 BaselCH
VITALITI GARAMI, AlessandraNovartis Pharma AG Postfach 4002 BaselCH
Information about Fees